Mochida Pharmaceutical Co.,Ltd. Logo

Mochida Pharmaceutical Co.,Ltd.

Develops and sells pharmaceuticals, healthcare products, and medical devices.

4534 | T

Overview

Corporate Details

ISIN(s):
JP3922800002
LEI:
Country:
Japan
Address:
新宿区四谷一丁目7番地

Description

Mochida Pharmaceutical Co., Ltd. is a research-driven company focused on the development, manufacturing, and sale of pharmaceuticals, healthcare products, and medical devices. The company's core pharmaceutical business concentrates on therapeutic areas such as cardiovascular diseases, with a key focus on circulatory agents. It is also active in other fields, including oncology, through partnerships for generic products. In its healthcare segment, Mochida develops and markets functional, low-irritating products based on dermatological science. Additionally, the company distributes medical instruments and equipment for diagnostic and surgical applications, contributing to a broad spectrum of medical care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-11-13 01:34
四半期報告書-第86期第2四半期(2023/07/01-2023/09/30)
Japanese 197.9 KB
2023-08-09 02:20
確認書
Japanese 8.7 KB
2023-08-09 02:19
四半期報告書-第86期第1四半期(2023/04/01-2023/06/30)
Japanese 152.0 KB
2023-06-29 06:55
確認書
Japanese 8.7 KB
2023-06-29 06:53
内部統制報告書-第85期(2022/04/01-2023/03/31)
Japanese 23.2 KB
2023-06-29 06:51
有価証券報告書-第85期(2022/04/01-2023/03/31)
Japanese 1.3 MB
2023-02-10 01:37
確認書
Japanese 8.6 KB
2023-02-10 01:35
四半期報告書-第85期第3四半期(2022/10/01-2022/12/31)
Japanese 164.5 KB
2022-11-11 02:02
確認書
Japanese 8.7 KB
2022-11-11 02:01
四半期報告書-第85期第2四半期(令和4年7月1日-令和4年9月30日)
Japanese 200.9 KB
2022-08-05 02:40
確認書
Japanese 9.1 KB
2022-08-05 02:38
四半期報告書-第85期第1四半期(令和4年4月1日-令和4年6月30日)
Japanese 154.4 KB
2022-06-29 06:44
確認書
Japanese 9.1 KB
2022-06-29 06:42
内部統制報告書-第84期(令和3年4月1日-令和4年3月31日)
Japanese 23.6 KB
2022-06-29 06:39
有価証券報告書-第84期(令和3年4月1日-令和4年3月31日)
Japanese 1.3 MB

Automate Your Workflow. Get a real-time feed of all Mochida Pharmaceutical Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mochida Pharmaceutical Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mochida Pharmaceutical Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.